Reciprocally, cardiac-specific overexpressing VCP protects mouse hearts against pressure-overload-induced pathological hypertrophy [15,16,17] and heart failure [18], and it also protects against stress-induced cardiomyocyte death in vitro and reduced ischemic injury in vivo [19,20,21]. This evidence concerns the gene VCP and heart failure.